141 related articles for article (PubMed ID: 10286003)
1. Contrast agents for MRI: present and future applications.
Health Technol; 1988; 2(1):33-6. PubMed ID: 10286003
[TBL] [Abstract][Full Text] [Related]
2. Future improvements in magnetic resonance imaging.
Health Technol; 1988; 2(1):12-9. PubMed ID: 10286000
[TBL] [Abstract][Full Text] [Related]
3. New drug makes MRI competitive but invasive.
Souhrada L
Hospitals; 1988 Mar; 62(6):106. PubMed ID: 3345991
[No Abstract] [Full Text] [Related]
4. MRI: what are its applications; what will it replace?
Health Technol; 1988; 2(1):3-11. PubMed ID: 10302212
[TBL] [Abstract][Full Text] [Related]
5. Future horizons in MR imaging.
Hyslop WB; Balci NC; Semelka RC
Magn Reson Imaging Clin N Am; 2005 May; 13(2):211-24. PubMed ID: 15935308
[TBL] [Abstract][Full Text] [Related]
6. Gauging MRI's value.
Kaufman L
Adm Radiol; 1989 Apr; 8(4):24-5. PubMed ID: 10293093
[No Abstract] [Full Text] [Related]
7. Is it now time to acquire magnetic resonance imaging? Issues and concerns.
J Health Care Technol; 1985; 2(1):23-50. PubMed ID: 10300489
[TBL] [Abstract][Full Text] [Related]
8. Contrast-enhanced magnetic resonance imaging of central nervous system tumors: agents, mechanisms, and applications.
Essig M; Weber MA; von Tengg-Kobligk H; Knopp MV; Yuh WT; Giesel FL
Top Magn Reson Imaging; 2006 Apr; 17(2):89-106. PubMed ID: 17198225
[TBL] [Abstract][Full Text] [Related]
9. Future perspectives for intraoperative MRI.
Jolesz FA
Neurosurg Clin N Am; 2005 Jan; 16(1):201-13. PubMed ID: 15561539
[TBL] [Abstract][Full Text] [Related]
10. Future prospects for fMRI in the clinic.
Sorensen AG
J Magn Reson Imaging; 2006 Jun; 23(6):941-4. PubMed ID: 16649201
[TBL] [Abstract][Full Text] [Related]
11. Clinical advantages of 3.0 T MRI over 1.5 T.
Willinek WA; Schild HH
Eur J Radiol; 2008 Jan; 65(1):2-14. PubMed ID: 18162354
[TBL] [Abstract][Full Text] [Related]
12. Functional tumor imaging with dynamic contrast-enhanced magnetic resonance imaging.
Choyke PL; Dwyer AJ; Knopp MV
J Magn Reson Imaging; 2003 May; 17(5):509-20. PubMed ID: 12720260
[TBL] [Abstract][Full Text] [Related]
13. Frontiers of brain mapping using MRI.
Harel N; Uğurbil K; Uludağ K; Yacoub E
J Magn Reson Imaging; 2006 Jun; 23(6):945-57. PubMed ID: 16649202
[TBL] [Abstract][Full Text] [Related]
14. Clinical and research applications of magnetic resonance imaging.
Mezrich RS
Med Device Technol; 1990; 1(3):46-50. PubMed ID: 10149428
[TBL] [Abstract][Full Text] [Related]
15. Magnetic resonance imaging (MRI) in clinical radiology: recent advances, future directions and planning.
Jagannathan NR
J Acad Hosp Adm; 1996 Jul-1997 Jan; 8-9(2-1):11-3. PubMed ID: 10166955
[No Abstract] [Full Text] [Related]
16. Tumor models and specific contrast agents for small animal imaging in oncology.
Ni Y; Wang H; Chen F; Li J; DeKeyzer F; Feng Y; Yu J; Bosmans H; Marchal G
Methods; 2009 Jun; 48(2):125-38. PubMed ID: 19328231
[TBL] [Abstract][Full Text] [Related]
17. Whole-body magnetic resonance imaging of healthy volunteers: pilot study results from the population-based SHIP study.
Hegenscheid K; Kühn JP; Völzke H; Biffar R; Hosten N; Puls R
Rofo; 2009 Aug; 181(8):748-59. PubMed ID: 19598074
[TBL] [Abstract][Full Text] [Related]
18. Cardiovascular MRI: its current and future use in clinical practice.
Rehwald WG; Wagner A; Sievers B; Kim RJ; Judd RM
Expert Rev Cardiovasc Ther; 2007 Mar; 5(2):307-21. PubMed ID: 17338674
[TBL] [Abstract][Full Text] [Related]
19. Usefulness of diffusion-weighted imaging and dynamic contrast-enhanced magnetic resonance imaging in the diagnosis of prostate transition-zone cancer.
Yoshizako T; Wada A; Hayashi T; Uchida K; Sumura M; Uchida N; Kitagaki H; Igawa M
Acta Radiol; 2008 Dec; 49(10):1207-13. PubMed ID: 19031184
[TBL] [Abstract][Full Text] [Related]
20. [Contrast agents in magnetic resonance imaging: development and problems].
Xu YK
Di Yi Jun Yi Da Xue Xue Bao; 2002 Sep; 22(9):769-71. PubMed ID: 12297425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
